Prozac®, Zoloft®, Paxil®, Luvox®, Celexa®, Effexor®, Wellbutrin®, and other antidepressants.
An editorial appearing in vol 3 no 1 of the journal Ethical Human Sciences and Services in which Dr. Breggin points out that the kind of research used to justify a ban on MDMA (the recreational drug Ecstasy) could also be used to justify a ban of SSRI antidepressants. fromprozac.pbreggin.2001.pdf
Report presented at the September 14, 2004 press conference sponsored by the Alliance for Human Research Protection (AHRP) at the FDA Public Hearing on Antidepressants and Suicide. fdapressconfsept142004.pdf
A report Dr. Breggin presented to the FDA in August 2004 detailing the relation of suicidality and violence to antidepressants fdaaug2304.pdf
Dangers of antidepressants. Newspaper column–shortened.pdf
SSRIs produce a continuum of stimulation that includes manic-like reactions, agitated depression, obsessive preoccupations, and akathisia. FDAspeech2.2.04.pdf
Ethical Human Psychology and Psychiatry, 7, 7-22, 2004. Simultaneously published in the International Journal of Risk and Safety in Medicine, 16, 247-259, 2005. recentus.pbreggin.2004.pdf
Journal of Humanistic Psychology, 43: 34-49, 2003. psychopharmacologyand.pbreggin.2003.pdf
International Journal of Risk and Safety in Medicine, 14: 71-86, 2002. Originally published in Ethical Human Sciences and Services, 4:211-227, 2002. fluvoxamine.pdf
Report filed with the court stating Dr. Breggin’s belief that Paxil induced Reynaldo Lacuzong to commit murder. Breggin Paxil Lacuzong Report Filed with Court.pdf
Breggin, PR. (2001) International Journal of Risk and Safety in Medicine, 14, 71-86. A comparison of the FDA-approved label for Luvox (fluvoxamine) with the known risks of fluvoxamine-induced stimulation, mania and aggression in adults and children. fluvoxamine.pdf
